Literature DB >> 23259539

Balantidium coli: an unrecognized cause of vertebral osteomyelitis and myelopathy.

Shashi Dhawan1, Deepali Jain, Veer Singh Mehta.   

Abstract

Balantidium coli is a ciliated protozoan parasite that primarily infects primates and pigs. It is the largest protozoan to infect humans and is a well-known cause of diarrhea and dysentery. Extraintestinal disease is uncommon, and extraintestinal spread to the peritoneal cavity, appendix, genitourinary tract, and lung has rarely been reported. The authors describe a case of vertebral osteomyelitis with secondary cervical cord compression caused by B. coli. The patient was a 60-year-old immunocompetent man presenting with quadriplegia of short duration. Magnetic resonance imaging of the cervical spine showed extradural and prevertebral abscess at the C3-4 level. Drainage of the abscess, C3-4 discectomy, and iliac bone grafting were performed. Histologically B. coli was confirmed in an abscess sample. To the best of the authors' knowledge, involvement of bone by B. coli has never been reported, and this case is the first documented instance of cervical cord compression due to B. coli osteomyelitis of the spine in the literature.

Entities:  

Mesh:

Year:  2012        PMID: 23259539     DOI: 10.3171/2012.11.SPINE12519

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  2 in total

1.  Prevalence of Balantidium coli (Malmsten, 1857) infection in swine reared in South Italy: A widespread neglected zoonosis.

Authors:  Filippo Giarratana; Luca Nalbone; Ettore Napoli; Vincenzo Lanzo; Antonio Panebianco
Journal:  Vet World       Date:  2021-04-30

Review 2.  Antibiotic Cement Utilization for the Prophylaxis and Treatment of Infections in Spine Surgery: Basic Science Principles and Rationale for Clinical Use.

Authors:  George M Anderson; Camilo Osorio; Ellis M Berns; Umar Masood; Daniel Alsoof; Christopher L McDonald; Andrew S Zhang; John Andrew Younghein; Eren O Kuris; Albert Telfeian; Alan H Daniels
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.